Phase III trial of everolimus in metastatic renal cell carcinoma: Subgroup ... - UroToday Print
UroToday

To assess the efficacy and safety of everolimus in Japanese patients with metastatic renal cell carcinoma. A subgroup analysis of the pivotal Phase III,

... phase iii trial of everolimus in metastatic renal cell carcinoma subgroup analysis of japanese patients from record1 abstract